Construction of Pcdna3.1(+) Glial Cell Line-Derived Neurotrophic Factor(gdnf) Vector and Its Expression in Eukaryotic Cells

赵永波,张莹,王枫,王乔树,王维治,李钰,张贵寅

DOI: https://doi.org/10.3760/cma.j.issn.1000-4955.2001.01.021

2001-01-01

Abstract:Objective To construct pcDNA3.1(+)GDNF recombinant eukaryoticexpression plasmid and to investigate its expression in eukaryotic cells. Methods The coding sequence of GDNF was amplified from rat astrocytes by reverse transcription PCR (RT-PCR) and cloned into pcDNA3.1(+) eukaryotic expression vector. The recombinant pcDNA3.1(+)GDNF plasmid was then transfected into eukaryotic cells mediated by using Fu Gene 6 method. Analysis by restricting enzyme digestion and DNA sequencing were carried out to demonstrate the sequence of the plasmid. GDNF protein and its activity were then determined using pcDNA3.1(+)GDNF plasmid transfected eukaryotic cells. Results RT-PCR product is 640 bp specific segment. Analysis by restricting enzyme digestion and DNA sequencing of pcDNA3.1(+)GDNF recombinant showed results from restricting enzyme were 640 bp and 300 bp segments respectively. DNA sequencing revealed that GDNF cloning was successful. The recombinant plasmid can express active GDNF protein in eukaryotic cells. Conclusion The study on the role of both GDNF and gene therapy is significant in the treatment of Parkinson disease.